natgillin/translations-raw huggingface dataset:
Box of 1 bottle of 100 doses
Škatla z 1 plastenko s 100 odmerki
Box of 1 bottle of 100 doses (1 x 100 ml)
Škatla z 1 plastenko s 100 odmerki (1 x 100 ml).
Box of 1 bottle of 50 doses
Škatla z 1 plastenko s 50 odmerki
Box of 1 bottle of 50 doses (1 x 50 ml)
Škatla z 1 plastenko s 50 odmerki (1 x 50 ml).
Box of 1 bottle.
Škatlica z eno steklenico.
BOX OF 1 MULTI-DOSE CONTAINER OF 10 DOSES
KARTONSKA ŠKATLA Z 1 VEČODMERNIM VSEBNIKOM Z 10 ODMERKI
Box of 1 or 2 blister card of 3 x 0.67 ml pipettes
Škatla z 1 ali 2 blistroma s 3 x 0,67 ml merilnimi kapalkami
Box of 1 or 2 blister card of 3 x 0.80 ml pipettes
Škatla z 1 ali 2 blistroma s 3 x 0,80 ml merilnimi kapalkami
Box of 1 or 2 blister card of 3 x 1.33 ml pipette
Škatla z 1 ali 2 blistroma s 3 x 1,33 ml merilnimi kapalkami
Box of 1 or 2 blister card of 3 x 1.60 ml pipettes Not all pack sizes may be marketed.
Škatla z 1 ali 2 blistroma s 3 x 1,60 ml merilnimi kapalkami Ni nujno, da so v prometu vsa navedena pakiranja.
Box of 1 or 2 blister card of 3 x 3.33 ml pipettes
Škatla z 1 ali 2 blistroma s 3 x 3,33 ml merilnimi kapalkami
Box of 1 or 2 blister card of 3 x 5.33 ml pipettes
Škatla z 1 ali 2 blistroma s 3 x 5,33 ml merilnimi kapalkami
Box of 1 or 2 blister card of 3 x 6.66 ml pipettes Not all pack sizes may be marketed.
Škatla z 1 ali 2 blistroma s 3 x 6,66 ml merilnimi kapalkami Ni nujno, da so v prometu vsa navedena pakiranja.
Box of 1 pipette.
Škatla z 1 merilno kapalko.
BOX OF 1 PRE-FILLED PEN
ŠKATLA Z 1 NAPOLNJENIM INJEKCIJSKIM PERESNIKOM
BOX OF 1 PRE-FILLED SYRINGE
ŠKATLA Z 1 NAPOLNJENO INJEKCIJSKO BRIZGO
BOX OF 1 PREFILLED PEN
ŠKATLA Z 1 NAPOLNJENIM INJEKCIJSKIM PERESNIKOM
Box of 1 vial
Škatla z 1 stekleničko
BOX OF 1 VIAL AND 1 PRE-FILLED SYRINGE
ŠKATLA Z 1 VIALO IN 1 NAPOLNJENO INJEKCIJSKO BRIZGO
BOX OF 1 VIAL AND 1 PRE-FILLED SYRINGE
ŠKATLA Z 1 VIALO PRAŠKA IN 1 NAPOLNJENO INJEKCIJSKO BRIZGO VEHIKLA
BOX OF 1 VIAL AND 1 PRE-FILLED SYRINGE BOX OF 7 VIALS AND 7 PRE-FILLED SYRINGES
ŠKATLA Z 1 VIALO IN 1 NAPOLNJENO INJEKCIJSKO BRIZGO ŠKATLA S 7 VIALAMI IN 7 NAPOLNJENIMI INJEKCIJSKIMI BRIZGAMI
BOX OF 1 VIAL AND 1 VIAL
ŠKATLA Z 1 VIALO PRAŠKA IN 1 VIALO VEHIKLA
BOX OF 1 VIAL AS PART OF A MULTIPACK COMPRISING 4 VIALS
ŠKATLA ZA 1 VIALO KOT DEL SKUPNEGA PAKIRANJA S 4 VIALAMI
BOX OF 1 VIAL BOX OF 4 VIALS BOX OF 10 VIALS
ŠKATLA ZA 1 VIALO ŠKATLA ZA 4 VIALE ŠKATLA ZA 10 VIAL
Box of 1 vial of lyophilisate and 1 vial of solvent
Škatla z 1 vialo liofilizata in 1 vialo z vehikla
Box of 1 vial of lyophilisate, 1 vial of solvent, 1 syringe and 1 needle.
Škatla z 1 vialo liofilizata, 1 vialo z vehikla, 1 vbrizgo in 1 iglo.
Box of 1 vial, or 5 vials.
Škatla vsebuje 1 vialo ali 5 vial.
Box of 1 x 1 dose
Škatla s 1 steklenicami po 1 dozo
BOX OF 1, 3, 10 VIALS OF POWDER AND SOLVENT
ŠKATLA Z 1, 3, 10 VIALAMI PRAŠKA IN VEHIKLA
BOX OF 1, 5, 10 VIALS AND 1, 5, 10 PRE-FILLED SYRINGES
ŠKATLA Z 1, 5, 10 VIALAMI PRAŠKA IN 1, 5, 10 NAPOLNJENIMI INJEKCIJSKIMI BRIZGAMI VEHIKLA
Box of 10
Škatla z 10
Box of 10
škatla z 10 x
Box of 10 bottles of 10 doses Box of 10 bottles of 50 doses Box of 10 bottles of 125 doses
Škatla z 10 steklenicami z 10 odmerki Škatla z 10 steklenicami s 50 odmerki Škatla z 10 steklenicami s 125 odmerki
Box of 10 bottles of 100 doses (10 x 100 ml)
Škatla z 10 plastenkami s 100 odmerki (10 x 100 ml).
Box of 10 bottles of 100 doses (10 x 100 ml).
Škatla z 10 plastenkami s 100 odmerki (1 x 100 ml).
Box of 10 bottles of 50 doses (10 x 50 ml)
Škatla z 10 plastenkami s 50 odmerki (10 x 50 ml).
Box of 10 bottles of 50 doses (10 x 50 ml).
Škatla z 10 plastenkami s 50 odmerki (1 x 50 ml).
Box of 10 liquid vials
Škatla z 10 vialami
Box of 10 lyophilisate vials and 10 solvent vials.
Škatla z 10 vialami liofilizata in 10 vialami vehikla.
Box of 10 or 50 lyophilisate vials and 10 or 50 solvent vials
Škatla z 10 ali 50 vialami liofilizata in 10 ali 50 vialami vehikla.
Box of 10 or 50 vials
Škatla z 10 ali 50 vialami
Box of 10 vials
Škatla z10 stekleničkami
Box of 10 vials of suspension for injection Box of 50 vials of suspension for injection Box of 2 vials of suspension for injection
Škatla z 10 vialamisuspenzije za injiciranje Škatla s 50 vialamisuspenzije za injiciranje Škatla z 2 vialamisuspenzije za injiciranje
Box of 10 vials.
Škatla z 10 vialami.
Box of 10 X 1 dose
Škatla s 10 steklenicami po 1 dozo
Box of 10 x 1 ml single dose syringes, 20 x 1 ml single dose syringes, 25 x 1 ml single dose syringes
ŠKATLA 10 x 1 ml enoodmerna brizga, 20 x 1 ml enoodmerna brizga, 25 x 1 ml enoodmerna brizga
Box of 10, 20, 30, 50, 60, 100
Škatla z 10, 20, 30, 50, 60, 100
Box of 10, 20, 30, 50, 60, 100, 120
Škatla z 10, 20, 30, 50, 60, 100, 120
Box of 10, 20, 30, 50, 60, 100, 200 tablets
Škatla z 10, 20, 30, 50, 60, 100 in 200 tabletami
Box of 15 x 1 dose
Škatla z 15 steklenicami po 1 dozo
Box of 2 vials
Škatla z 2 stekleničkami
Box of 2 x 1 bottle, 2 x 10 bottles and 2 x 50 bottles
Škatla s po 2x1 vialo, 2x10 vial in 2x50 vial
Box of 2 x 1 bottle, 2 x 10 bottles and 2 x 50 bottles.
Škatla s po 2x1 vialo, 2x10 vial in 2x50 vial.
Box of 2, 4 or 10 single-dose pre-filled syringes
Škatla z 2,4, 5, 10, ali 25 enoodmernimi napolnjemi brizgami
Box of 20
škatla z 20 x
Box of 20 or 60 tablets
Škatla z 20 ali 60 tabletami
Box of 20, 30, 50, 60, 100
Škatla z 20, 30, 50, 60, 100
Box of 20, 30, 50, 60, 80, 100, 120
Škatla z 20, 30, 50, 60, 80, 100, 120
Box of 20, 30, 60 or 90 tablets
Škatla z 20, 30, 60 ali 90 tabletami
Box of 200 (2 x 100) containing blue box
Škatla z 200 (2 x 100) tabletami, ki vsebuje modro okence
Box of 200 (2 x 100) with blue box
Škatla z 200 (2 x 100) tabletami z modrim okencem
Box of 200 (2 x 100) with blue box
Škatla z 200 (2 x 100) tabletami, ki vsebuje modro okence
BOX OF 28 PATCHES –TREATMENT INITIATION PACK – 4 WEEK TREATMENT SCHEDULE
ŠKATLA Z 28 OBLIŽI – PAKIRANJE ZA ZAČETNO ZDRAVLJENJE – 4-TEDENSKI RAZPORED ZDRAVLJENJA
Box of 3 vials of lyophilisate and 3 vials of solvent
Škatla s 3 vialami liofilizata in 2 vialami z vehikla
Box of 3 x 1 dose
Škatla s 3 steklenicami po 1 dozo
Box of 30 or 60 tablets
Škatla s 30 ali 60 tabletami
Box of 30 or 60 tablets
Škatla z 30 ali 60 tabletami
Box of 30 X 1 dose
Škatla s 30 steklenicami po 1 dozo
Box of 4 pipettes.
Škatla s 4 merilnimi kapalkami.
Box of 5 vials
Škatla s 5 stekleničkami
Box of 5 vials of lyophilisate and 5 vials of solvent
Škatla s 5 vialami liofilizata in 5 vialami z vehikla
Box of 5 X 1 dose
Škatla s 5 steklenicami po 1 dozo
BOX OF 5, 10, 50, 100 or 200 PIPETTES
ŠKATLA S 5, 10, 50, 100 ali 200 KAPALKAMI
BOX OF 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 ORODISPERSIBLE TABLETS
ŠKATLA Z 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 100 ORODISPERZIBILNIH TABLET
Box of 50
škatla s 50 x
Box of 50 liquid vials
Škatla s 50 vialami
Box of 50 lyophilisate vials and 50 solvent vials.
Škatla s 50 vialami liofilizata in 50 vialami vehikla.
Box of 50 vials.
Škatla s 50 vialami.
Box of 6 pipettes of 0.5 ml, 1 ml, 2 ml, 4 ml or 6 ml Not all pack sizes may be marketed.
Škatla s 6 merilnimi kapalkami po 0,5 ml, 1 ml, 2 ml, 4 ml ali 6 ml Ni nujno, da so v prometu vsa navedena pakiranja.
Box of 6 pipettes.
Škatla s 6 merilnimi kapalkami.
BOX OF 6 X 8.8 MICROGRAMS PRE-FILLED PENS + 6 X 22 MICROGRAMS PRE- FILLED PENS
ŠKATLA S 6 X 8,8 MIKROGRAMOV V NAPOLNJENIH INJEKCIJSKIH PERESNIKIH + 6 X 22 MIKROGRAMOV V NAPOLNJENIH INJEKCIJSKIH PERESNIKIH
BOX OF 6 X 8.8 MICROGRAMS SYRINGES + 6 X 22 MICROGRAMS SYRINGES
ŠKATLA S 6 X 8,8 MIKROGRAMOV V INJEKCIJSKI BRIZGI + 6 X 22 MIKROGRAMOV V INJEKCIJSKI BRIZGI
Box of 7, 14 or 28 tablets
Škatla s 7, 14 ali 28 tabletami
Box of 7, 14 or 28 tablets
Škatla z 7, 14 ali 28 tabletami
BOX OF 84 PATCHES CONTAINING 2 BOXES OF 42 PATCHES
ŠKATLA S 84 OBLIŽI, KI VSEBUJE 2 ŠKATLI S PO 42 OBLIŽI
BOX OF 84 PATCHES CONTAINING 2 BOXES OF 42 PATCHES
ŠKATLA S 84 OBLIŽI, KI VSEBUJE 2 ŠKATLI S PO 42 OBLIŽI.
Box of diluent
Škatla z vehiklom
Box of suspension
Škatla s suspenzijo
Box with 1 vial of 10 ml (10 doses).
Škatla z 1 vialo po10 ml (10 odmerkov).
Box with 10, or 50 vials of 1 ml Box with 1 vial of 10 ml
Škatla z 10 ali 50 vialami po 1 ml Škatla z 1 vialo po10 ml
Box with 5, 10, 25 or 50 vials of 1 ml (1 dose).
Škatla s 5, 10, 25 ali 50 vialami po 1 ml (1 odmerek)
Box with 5, 10, 25 or 50 vials of 1 ml Box with 1 vial of 10 ml
Škatla s 5, 10, 25 ali 50 vialami po 1 ml Škatla z 1 vialo po10 ml
BOX/OUTER CARTON
ŠKATLA
Boxed statements as follows:
Izjave v okvirčkih, kot sledi:
Boxes containing:
Škatle vsebujejo:
Boxes of 1 vial of 10 or 50 doses
Škatla z 1 vialo z 10 ali 50 odmerki
Boxes of 12 or 24 single-use polyester/aluminium foil sachets, containing 250 mg of cream.
Škata po 12 ali 24 vrečk za enkratno uporabo iz poliesterske/aluminijske folije, vsaka vsebuje 250 mg kreme.
Boxes of 30, 60 and 90 sachets.
Škatle s 30, 60 in 90 vrečkami.
BP-CML/Ph+ ALL (N=94) (%)
BP-KML/Ph+ ALL (N = 94) (%)
BPD-DA is also a photosensitiser but its systemic exposure is low (5-10% of the verteporfin exposure, suggesting that most of the active substance is eliminated unchanged).
Tudi BPD-DA je fotosenzitizator, vendar gre pri njem za majhno sistemsko izpostavljenost (5–10 % izpostavljenosti verteporfinu, kar kaže na to, da se večina zdravilne učinkovine odstrani iz telesa v nespremenjeni obliki).
BPI mean change from baseline
Srednja sprememba BPI od izhodišča
BR-CAP
BzR-CAP
BR-CAP= bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone; R-CHOP= rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; PN=peripheral neuropathy
BR-CAP=bortezomib, rituksimab, ciklofosfamid, doksorubicin in prednizon; R-CHOP= rituksimab, ciklofosfamid, doksorubicin, vinkristin in prednizon; PN=periferna nevropatija
Bracco International B.V. Strawinskylaan 3051
Imetnik dovoljenja za promet Bracco International B.V. Strawinskylaan 3051
Bradley, IL 60915 United States
Bradley, IL 60915 Združene države Amerike
Brady- and tachyarrhythmias have been reported.
Poročali so o upočasnjenem in pospešenem srčnem utripu.
Bradycardia
bradikardijo
bradycardia
inkopa, bradikardija
Bradycardia (abnormally low heart rate),
bradikardija (neobičajno počasen srčni utrip),
Bradycardia (Bradycardia, Heart rate decreased, Sinus bradycardia).
bradikardija (bradikardija, upočasnjen srčni utrip, sinusna bradikardija)
Bradycardia <50 beats per minute (bpm)
Bradikardija < 50 utripov na minuto.
Bradycardia as an infusion related adverse reaction
Bradikardija kot neželen učinek, povezan z infundiranjem
Bradycardia Atrioventricular block
bradikardija atrioventrikularni blok
Bradycardia below the following limits:
Bradikardija pod naslednjimi mejami:
Bradycardia has been reported during clinical studies; therefore, use crizotinib with caution due to the risk of excessive bradycardia when used in combination with other bradycardic agents (e.g., non-dihydropyridine calcium channel blockers such as verapamil and diltiazem, beta-blockers, clonidine, guanfacine, digoxin, mefloquine, anticholinesterases, pilocarpine) (see sections 4.2 and 4.4).
Med kliničnimi študijami so poročali o bradikardiji; krizotinib je torej treba uporabljati previdno, kadar se uporablja skupaj z drugimi zdravili, ki povzročajo bradikardijo (npr. nedihidropiridinski zaviralci kalcijevih kanalčkov, kot sta verapamil in diltiazem, antagonisti adrenergičnih receptorjev beta, klonidin, guanfacin, digoksin, meflokin, antiholinesteraze, pilokarpin), zaradi tveganja za pojav preveč izrazite bradikardije (glejte poglavji 4.2 in 4.4).
Bradycardia is also a well-known pharmacological effect from systemic beta blocker treatment.
Bradikardija je prav tako dobro znan farmakološki učinek sistemskega zdravljenja z zaviralci beta.
Bradycardia is defined below the following limits:
Bradikardija je definirana pod naslednjimi mejami:
Bradycardia may develop when alpha-2-agonists are used with sevoflurane.
Kadar se uporabljajo alfa-2- agonisti s sevofluranom, se utegne razviti bradikardija.
Bradycardia may develop when alpha-2-agonists are used with sevoflurane.
Kadar se uporabljajo alfa-2-agonisti s sevofluranom, se utegne razviti bradikardija.
Bradycardia may occasionally lead to cardiac arrest. (See section 4.8.) Patients should be closely monitored for hemodynamic changes during and after reversal of neuromuscular blockade.
Bradikardija lahko občasno vodi do srčnega zastoja. (glejte poglavje 4.8) Bolnike je treba med in po prekinitvi blokade živčnomišičnega prenosa skrbno opazovati glede hemodinamičnih sprememb.
Bradycardia Tachycardia
Redki: tahikardija
Bradycardia was evaluated as a potential safety signal and 15 cases were reviewed.
Bradikardija je bila ocenjena kot potencialni varnostni signal in obravnavanih je bilo 15 primerov.
bradycardia weight increase/risk of obesity
bradikardije, zvečanja telesne mase /tveganja debelosti.
Bradycardia –inducing calcium-channel blockers (diltiazem, verapamil, bepridil)
Zaviralci kalcijevih kanalčkov (diltiazem, verapamil, bepridil), ki povzročajo bradikardijo
bradycardia, cardiovascular disorder
bradikardija, bolezen srca in ožilja
bradycardia, cardiovascular disorder
bradikardija, kardiovaskularne motnje
bradycardia, tachycardia
tahikardija
Bradycardia, tachycardia, cyanosis
bradikardija, tahikardija, cianoza
bradycardia.. arrhythmia, heart rate irregular cardiac failure, tachycardia, chest pain palpitations.
srčno popuščanje, tahikardija, bolečine v prsih, palpitacije
Bradycardiaa (life-threatening consequences, urgent intervention indicated)
bradikardijaa (z življenjsko nevarnimi posledicami, potrebni so nujni ukrepi)
Bradycardiaa (symptomatic, may be severe and medically significant, medical intervention indicated)
bradikardijaa (simptomatska, lahko huda in zdravstveno pomembna, potrebni so zdravstveni ukrepi)
Bradycardiab (following abrupt discontinuation of therapy)
bradikardijab (po nenadni prekinitvi zdravljenja)
Bradycardiac
bradikardijac
Bradycardiag (13%)
bradikardijag (13 %)
Bradyphrenia Disturbance in attention Nystagmus Paraesthesia Speech disorder Tremor
bradifrenija motnje pozornosti nistagmus parestezije motnje govora tremor
BRAF V600E (Primary)
BRAF V600E (primarni)
brain
0,00
Brain
0,008
Brain
0,017
brain
možgani
Brain abscess Cellulitis Sepsis
možganski absces celulitis sepsa
Brain abscess Cellulitis Sepsis
možganski absces, celulitis, sepsa
Brain disease
bolezen možgan
Brain haemorrhage
krvavitve v možganih
Brain imaging, preferably Magnetic Resonance Imaging (MRI), is used to confirm the diagnosis.
Diagnozo potrdimo s slikovnimi preiskavami možganov, najbolje z magnetnoresonančnim slikanjem (MRI – Magnetic Resonance Imaging).
Brain metastasis Stable brain metastasis
Metastaze v možganih Stabilne metastaze v možganih
Brain oedema
možganski edem
brain oedema, encephalopathy4, extrapyramidal disorder5, neuropathy peripheral, ataxia, hypoaesthesia,
možganski edem, encefalopatija4, ekstrapiramidne motnje5, periferna nevropatija, ataksija, hipestezija, disgevzija
brain oedema, encephalopathy4, extrapyramidal disorder5, neuropathy peripheral, ataxia, hypoaesthesia, dysgeusia
možganski edem, encefalopatija4, ekstrapiramidne motnje5, periferna nevropatija, ataksija, hipestezija, disgevzija
Brain3
možgani3
Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG UK
Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG, UK
Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG,
Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG
Brampton Road, Hampden Park, Eastbourne, East Sussex - BN22 9AG
Brampton Road, Hampden Park, Eastbourne East Sussex - BN22 9AG
Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG United Kingdom
Brampton Road, Hampden Park Eastbourne, East Sussex, BN22 9AG Velika Britanija
Bravecto 112.5 mg (2–4.5 kg) Bravecto 250 mg (>4.5 –10 kg) Bravecto 500 mg (>10 –20 kg) Bravecto 1000 mg (>20 –40 kg) Bravecto 1400 mg (>40 –56 kg)
Bravecto 112,5 mg (2-4,5 kg) Bravecto 250 mg (>4.5-10 kg) Bravecto 500 mg (>10-20 kg) Bravecto 1000 mg (>20-40 kg) Bravecto 1400 mg (>40-56 kg)
Bravecto 112.5 mg chewable tablets for very small dogs (2–4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5 –10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10 –20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20 –40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40–56 kg)
Bravecto 112.5 mg žvečljive tablete za zelo majhne pse (2-4,5 kg) Bravecto 250 mg žvečljive tablete za majhne pse (>4.5-10 kg) Bravecto 500 mg žvečljive tablete za srednje velike pse (>10-20 kg) Bravecto 1000 mg žvečljive tablete za velike pse (>20-40 kg) Bravecto 1400 mg žvečljive tablete za zelo velike pse (>40-56 kg)
Bravecto 112.5 mg chewable tablets for very small dogs (2–4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5 –10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10–20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20–40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40–56 kg)
Bravecto 112,5 mg žvečljive tablete za zelo majhne pse (2-4,5 kg) Bravecto 250 mg žvečljive tablete za majhne pse (>4.5-10 kg) Bravecto 500 mg žvečljive tablete za srednje velike pse (>10-20 kg) Bravecto 1000 mg žvečljive tablete za velike pse (>20-40 kg) Bravecto 1400 mg žvečljive tablete za zelo velike pse (>40-56 kg)
Bravecto 112.5 mg chewable tablets for very small dogs (2–4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5–10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10–20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20–40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40–56 kg)
Bravecto 112,5 mg žvečljive tablete za zelo majhne pse (2-4,5 kg) Bravecto 250 mg žvečljive tablete za majhne pse (>4.5-10 kg) Bravecto 500 mg žvečljive tablete za srednje velike pse (>10-20 kg) Bravecto 1000 mg žvečljive tablete za velike pse (>20-40 kg) Bravecto 1400 mg žvečljive tablete za zelo velike pse (>40-56 kg)
Bravecto 112.5 mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg spot-on solution for large cats (>6.25 – 12.5 kg)
Bravecto 112,5 mg kožni nanos, raztopina za majhne mačke (1,2 – 2,8 kg) Bravecto 250 mg kožni nanos, raztopina za srednje velike mačke (>2,8 – 6,25 kg) Bravecto 500 mg kožni nanos, raztopina za velike mačke (>6,25 – 12,5 kg)
Bravecto 112.5 mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg spot-on solution for large cats (>6.25 – 12.5 kg)
Bravecto 112,5 mg kožni nanos, raztopina za majhne mačke (1,2 – 2,8 kg) Bravecto 250 mg kožni nanos, raztopina za srednje velike mačke (>2,8 – 6,25 kg) Bravecto 500 mg kožni nanos, raztopina za velike mačke (>6.,5 – 12,5 kg)
Bravecto 112.5 mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg spot-on solution for large cats (>6.25 – 12.5 kg) fluralaner
Bravecto 112,5 mg kožni nanos, raztopina za majhne mačke (1,2 – 2,8 kg) Bravecto 250 mg kožni nanos, raztopina za srednje velike mačke (>2,8 – 6,25 kg) Bravecto 500 mg kožni nanos, raztopina za velike mačke (>6,25 – 12,5 kg)
Bravecto 112.5 mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg spot-on solution for large cats (>6.25 – 12.5 kg) fluralaner
Bravecto 112,5 mg kožni nanos, raztopina za majhne mačke (1,2 – 2,8 kg) Bravecto 250 mg kožni nanos, raztopina za srednje velike mačke (>2,8 – 6,25 kg) Bravecto 500 mg kožni nanos, raztopina za velike mačke (>6.,5 – 12,5 kg) fluralaner
Bravecto 112.5 mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg spot-on solution for large cats (>6.25 – 12.5 kg) fluralaner
Bravecto 112.5 mg kožni nanos, raztopina za majhne mačke (1,2 – 2,8 kg) Bravecto 250 mg kožni nanos, raztopina za srednje velike mačke (>2,8 – 6,25 kg) Bravecto 500 mg kožni nanos, raztopina za velike mačke (>6,25 – 12,5 kg) fluralaner
Bravecto 112.5 mg spot-on solution for very small dogs (2 – 4.5 kg) Bravecto 250 mg spot-on solution for small dogs (>4.5 – 10 kg) Bravecto 500 mg spot-on solution for medium-sized dogs (>10 – 20 kg) Bravecto 1000 mg spot-on solution for large dogs (>20 – 40 kg) Bravecto 1400 mg spot-on solution for very large dogs (>40 – 56 kg)
Bravecto 112,5 mg kožni nanos, raztopina za zelo majhne pse (2-4,5 kg) Bravecto 250 mg kožni nanos, raztopina za majhne pse (>4,5-10 kg) Bravecto 500 mg kožni nanos, raztopina za srednje velike pse (>10-20 kg) Bravecto 1000 mg kožni nanos, raztopina za velike pse (>20-40 kg) Bravecto 1400 mg kožni nanos, raztopina za zelo velike pse (>40-56 kg)
Bravecto 112.5 mg spot-on solution for very small dogs (2 – 4.5 kg) Bravecto 250 mg spot-on solution for small dogs (>4.5 – 10 kg) Bravecto 500 mg spot-on solution for medium-sized dogs (>10 – 20 kg) Bravecto 1000 mg spot-on solution for large dogs (>20 – 40 kg) Bravecto 1400 mg spot-on solution for very large dogs (>40 – 56 kg) fluralaner
Bravecto 112,5 mg kožni nanos, raztopina za zelo majhne pse (2-4,5 kg) Bravecto 250 mg kožni nanos, raztopina za majhne pse (>4,5-10 kg) Bravecto 500 mg kožni nanos, raztopina za srednje velike pse (>10-20 kg) Bravecto 1000 mg kožni nanos, raztopina za velike pse (>20-40 kg) Bravecto 1400 mg kožni nanos, raztopina za zelo velike pse (>40-56 kg) fluralaner
Bravecto 112.5 mg spot-on solution for very small dogs (2-4.5 kg) Bravecto 250 mg spot-on solution for small dogs (>4.5 – 10 kg) Bravecto 500 mg spot-on solution for medium-sized dogs (>10 - 20 kg) Bravecto 1000 mg spot-on solution for large dogs (>20 – 40 kg) Bravecto 1400 mg spot-on solution for very large dogs (>40 – 56 kg) fluralaner
Bravecto 112,5 mg kožni nanos, raztopina za zelo majhne pse (2-4,5 kg) Bravecto 250 mg kožni nanos, raztopina za majhne pse (>4,5-10 kg) Bravecto 500 mg kožni nanos, raztopina za srednje velike pse (>10-20 kg) Bravecto 1000 mg kožni nanos, raztopina za velike pse (>20-40 kg) Bravecto 1400 mg kožni nanos, raztopina za zelo velike pse (>40-56 kg) fluralaner
Bravecto can only be obtained with a prescription.
Izdaja zdravila je le na recept.
Bravecto chewable tablets for dogs
Bravecto žvečljive tablet za pse
Bravecto chewable tablets should be administered in accordance with the following table (corresponding to a dose of 25–56 mg fluralaner/kg bodyweight within one weight band):
Bravecto je treba dajati v skladu z naslednjo preglednico (en odmerek 25-56 mg fluralanerja /kg telesne teže v eni skupini):
Bravecto contains the active substance fluralaner.
Zdravilo Bravecto vsebuje zdravilno učinkovino fluralaner.
Bravecto is a chewable tablet and is well accepted by most dogs.
Bravecto je žvečljiva tableta in jo večina psov dobro sprejme.
Bravecto is a veterinary medicine used to treat flea and tick infestations in dogs and cats.
Zdravilo Bravecto je zdravilo za uporabo v veterinarski medicini, ki se uporablja za zdravljenje infestacij z bolhami in klopi pri psih in mačkah.
Bravecto is available as a spot-on solution in a pipette for use on dogs and cats and as chewable tablets for use in dogs.
Zdravilo Bravecto je na voljo v obliki raztopine za kožni nanos v merilni kapalki za uporabo pri psih in mačkih ter v obliki žvečljivih tablet za uporabo pri psih.
Bravecto should be administered in accordance with the following table (corresponding to a dose of 25-56 mg fluralaner/kg body weight):
Zdravilo Bravecto je treba dajati v skladu z naslednjo preglednico (en odmerek 25-56 mg fluralanerja/kg telesne teže ):
Bravecto should be administered in accordance with the following table (corresponding to a dose of 25–56 mg fluralaner/kg bodyweight within one weight band):
Bravecto je treba dajati v skladu z naslednjo preglednico (en odmerek 25-56 mg fluralanerja /kg telesne teže v eni skupini):
Bravecto should be administered in accordance with the following table (corresponding to a dose of 40 – 94 mg fluralaner/kg body weight):
Bravecto je treba dajati v skladu z naslednjo preglednico (en odmerek 40 – 94 mg fluralanerja/kg telesne teže ):
Bravecto should be administered in accordance with the following table (corresponding to a dose of 40 – 94 mg fluralaner/kg body weight):
Bravecto je treba dajati v skladu z naslednjo preglednico (en odmerek 40-94 mg fluralanerja/kg telesne teže ):